GRM2 and neurodegenerative disease: While the neuroprotective effects of LY 379268 and JNJ-46281222 have been extensively explored in the literature, with their therapeutic potential for neurodegenerative diseases investigated, our study introduces groundbreaking evidence that THRX-195518, functioning as a mGlu2 PAM, may be a candidate drug molecule with protective potential against Glu toxicity.